Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,885.57
3,192.30
3,751.87
3,663.17
3,708.51
3,084.36
3,286.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,885.57
3,192.30
3,751.87
3,663.17
3,708.51
3,084.36
3,286.31
Raw Material Cost
1,799.03
1,836.47
2,105.49
1,950.33
2,007.31
1,723.61
1,712.95
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
21.24
29.73
37.61
49.97
48.70
43.36
44.66
Selling and Distribution Expenses
679.61
860.22
1,268.90
1,334.04
1,349.97
1,025.08
1,073.45
Other Expenses
9.99
16.30
11.24
8.15
7.51
8.28
8.85
Total Expenditure (Excl Depreciation)
2,599.76
2,889.44
3,524.41
3,415.81
3,481.07
2,874.79
2,919.62
Operating Profit (PBDIT) excl Other Income
285.79999999999995
302.9
227.5
247.39999999999998
227.39999999999998
209.60000000000002
366.70000000000005
Other Income
28.18
41.19
55.81
15.12
23.24
36.72
26.19
Operating Profit (PBDIT)
564.51
597.13
489.56
453.53
411.00
385.44
503.04
Interest
21.24
29.73
37.61
49.97
48.70
43.36
44.66
Exceptional Items
-122.95
-34.95
-10.54
-131.87
-5.54
-44.23
-1.01
Gross Profit (PBDT)
1,086.54
1,355.84
1,646.38
1,712.84
1,701.20
1,360.75
1,573.35
Depreciation
295.79
296.84
272.90
257.22
209.30
184.26
162.61
Profit Before Tax
124.53
235.61
168.51
14.47
147.45
113.60
294.75
Tax
0.05
18.30
5.57
-5.92
40.40
31.80
76.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
70.56
133.45
117.05
35.41
48.67
33.98
161.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
70.56
133.45
117.05
35.41
48.67
33.98
161.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
51.49
74.76
45.62
-16.97
60.00
46.60
51.91
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
122.05
208.21
162.67
18.44
108.67
80.58
213.67
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,034.34
3,057.35
2,953.55
2,972.51
2,993.03
2,991.52
3,011.97
Earnings per share (EPS)
0.06
0.12
0.11
0.03
0.04
0.03
0.15
Diluted Earnings per share
0.06
0.12
0.11
0.03
0.04
0.03
0.15
Operating Profit Margin (Excl OI)
8.34%
8.12%
4.29%
4.95%
4.81%
5.33%
9.56%
Gross Profit Margin
14.57%
16.68%
11.77%
7.42%
9.62%
9.66%
13.92%
PAT Margin
2.45%
4.18%
3.12%
0.97%
1.31%
1.1%
4.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -9.61% vs -14.92% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -41.35% vs 27.97% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -3.53% vs 28.15% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -28.62% vs -21.01% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Tianjin Tianyao Pharmaceuticals Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,885.57
0
2,885.57
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,885.57
0
2,885.57
Raw Material Cost
1,799.03
0
1,799.03
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
21.24
0
21.24
Selling and Distribution Expenses
679.61
0
679.61
Other Expenses
9.99
0.00
9.99
Total Expenditure (Excl Depreciation)
2,599.76
0
2,599.76
Operating Profit (PBDIT) excl Other Income
285.80
0.00
285.80
Other Income
28.18
0
28.18
Operating Profit (PBDIT)
564.51
0
564.51
Interest
21.24
0
21.24
Exceptional Items
-122.95
0
-122.95
Gross Profit (PBDT)
1,086.54
0
1,086.54
Depreciation
295.79
0
295.79
Profit Before Tax
124.53
0
124.53
Tax
0.05
0
0.05
Provisions and contingencies
0
0
0.00
Profit After Tax
70.56
0
70.56
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
70.56
0
70.56
Share in Profit of Associates
0
0
0.00
Minority Interest
51.49
0
51.49
Other related items
0.00
0.00
0.00
Consolidated Net Profit
122.05
0
122.05
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,034.34
0
3,034.34
Earnings per share (EPS)
0.06
0
0.06
Diluted Earnings per share
0.06
0
0.06
Operating Profit Margin (Excl OI)
8.34%
0%
0.00
8.34%
Gross Profit Margin
14.57%
0%
0.00
14.57%
PAT Margin
2.45%
0%
0.00
2.45%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 288.56 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -9.61% vs -14.92% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 12.21 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -41.35% vs 27.97% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 53.63 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -3.53% vs 28.15% in Dec 2024
Annual - Interest
Interest 2.12 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -28.62% vs -21.01% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.34%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






